Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mammalian cells coexpress a family of heat shock factors (HSFs) whose activities are regulated by diverse stress conditions to coordinate the inducible expression of heat shock genes. Distinct from HSF1, which is expressed ubiquitously and activated by heat shock and other stresses that result in the appearance of nonnative proteins, the stress signal for
HSF2
has not been identified.
HSF2
activity has been associated with development and differentiation, and the activation properties of
HSF2
have been characterized in hemin-treated human K562 erythroleukemia cells. Here, we demonstrate that a stress signal for
HSF2
activation occurs when the ubiquitin-proteasome pathway is inhibited.
HSF2
DNA-binding activity is induced upon exposure of mammalian cells to the proteasome inhibitors hemin, MG132, and lactacystin, and in the mouse ts85 cell line, which carries a temperature sensitivity mutation in the
ubiquitin-activating enzyme
(E1) upon shift to the nonpermissive temperature.
HSF2
is labile, and its activation requires both continued protein synthesis and reduced degradation. The downstream effect of
HSF2
activation by proteasome inhibitors is the induction of the same set of heat shock genes that are induced during heat shock by HSF1, thus revealing that
HSF2
affords the cell with a novel heat shock gene-regulatory mechanism to respond to changes in the protein-degradative machinery.
...
PMID:Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway. 971 May 93